<?xml version="1.0" encoding="UTF-8"?>
<p id="par0020">On March 11, 2020, The World Health Organization (WHO) has declared the novel coronavirus (COVID-19) outbreak a global pandemic. On March 28, 2020, United States Food and Drug Administration (FDA) issued an emergency use authorization of hydroxychloroquine sulfate (Plaquenil®, Quineprox®), chloroquine phosphate (Aralen®), in which the physicians can prescribe those to seriously hospitalized COVID-19 patients. Later in June 15, 2020 FDA revoked their use based on serious side effects and no real benefits on clinical trials [
 <xref rid="bib0050" ref-type="bibr">10</xref>]. As of September 28, 2020, the coronavirus disease 2019 (COVID-19) pandemic had resulted in 33,270,108 cases and 1,001,497 deaths worldwide, including 7,317,312 cases and 209,423 deaths in the United States (US) [
 <xref rid="bib0055" ref-type="bibr">11</xref>].
</p>
